Strides Pharma Science Limited has posted net profit of Rs. 29.21 crores for the period ended March 31, 2022 as against net loss of Rs. 121.671 crores for the period ended December 31, 2021. The company posted net profit of Rs.46.086 crores for the period ended March 31, 2021.

The company has reported total income of Rs. 952.07 crores during the period ended March 31, 2022 as compared to Rs. 804.58 crores during the period ended December 31, 2021. It reported total income of Rs.921.541 crores during the period ended March 31, 2021.

The company has reported total income of Rs.3202.23 crores during the Financial Year ended March 31, 2022 as compared to Rs.3367.29 crores during the Financial Year ended March 31, 2021.

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022 as against net profit of Rs.268.44 crores for the Financial Year ended March 31, 2021.